Sun Pharma Surges By 5%; BSE Healthcare Index Up 0.9%

SUN PHARMA share price has zoomed 5% and is presently trading at Rs 420.

Meanwhile, the BSE HEALTHCARE Index is at 13,967 (up 0.9%).

Among the top Gainers in the BSE HEALTHCARE Index today are SUN PHARMA (up 5.3%) and SUN PHARMA ADV. RES. (up 7.2%).

ABBOTT INDIA and WOCKHARDT LTD. are among the top losers today.

Over the last one year, SUN PHARMA has moved down from Rs 576 to Rs 420, registering a loss of Rs 156 (down 27.2%).

On the other hand, the BSE HEALTHCARE has moved down from 14,966 to 13,967, loss of 999 points (down 6.7%) during the last 12 months.

The top gainers among the BSE HEALTHCARE Index stocks during this same period were ABBOTT INDIA (up 49.0%), DIVIS LABORATORIES (up 40.0%) and SANOFI INDIA (up 36.4%).

What About the Benchmark Indices?

The BSE Sensex is at 36,650 (down 0.4%).

The top gainers among the BSE Sensex stocks today are SUN PHARMA (up 5.3%), KOTAK MAH. BANK (up 2.9%) and BAJAJ FINANCE (up 1.1%). Other gainers include ONGC (up 0.2%) and BHARTI AIRTEL (up 0.1%). The most traded stocks in the BSE Sensex are SUN PHARMA and KOTAK MAH. BANK.

In the meantime, NSE Nifty is at 10,950 (down 0.4%). SUN PHARMA (up 5.4%) and KOTAK MAH. BANK (up 3.0%) are among the top gainers in NSE Nifty.

Over the last 12 months, the BSE Sensex has moved up from 35,798 to 36,650, registering a gain of 852 points (up 1.8%).

SUN PHARMA Financial Update...

SUN PHARMA net profit down at Rs 1 billion for the quarter ended September 2018, compared to a loss of Rs 4 billion a year ago. Net Sales rose 4.3% to Rs 69.4 billion during the period as against Rs 66.5 billion in July-September 2017.

For the year ended March 2018, SUN PHARMA reported 54.3% decrease in net profit to Rs 35.8 billion compared to net profit of Rs 78.4 billion during FY17.

Revenue of the company grew 16.1% to Rs 265 billion during FY18.

The current Price to earnings ratio of SUN PHARMA, based on rolling 12 month earnings, stands at 34.1x.